Tempest Therapeutics, Inc. Total Long-Term Debt
Tempest Therapeutics, Inc. (TPST) had Total Long-Term Debt of $4.20 million as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2025-05-13
- 2025-03-31: Long-term Debt $4.20M.
- 2024-12-31: Long-term Debt $6.40M.
- 2024-09-30: Long-term Debt $8.50M.
- 2024-06-30: Long-term Debt $10.70M.
| Period end | Long-term Debt |
|---|---|
| 2025-03-31 | $4.20M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.40M 10-K · filed 2025-03-27 |
| 2024-09-30 | $8.50M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $10.70M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $10.60M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $10.50M 10-K · filed 2024-03-19 |
| 2023-09-30 | $10.50M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $10.50M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $10.40M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $10.40M 10-K · filed 2023-03-22 |
| 2022-09-30 | $15.34M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $15.30M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |